Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
Price:
44.04 USD
-4.09%
Market Closed
Updated:
May 18, 2024
Corbus Pharmaceuticals Holdings Inc
Total Other Income
|
Corbus Pharmaceuticals Holdings Inc
Total Other Income Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Corbus Pharmaceuticals Holdings Inc
NASDAQ:CRBP
|
Total Other Income
$3.4m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$4.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-204%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$252m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$15.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-61%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Corbus Pharmaceuticals Holdings Inc's Total Other Income?
Total Other Income
3.4m
USD
3.4m
USD
Based on the financial report for Dec 31, 2023, Corbus Pharmaceuticals Holdings Inc's Total Other Income amounts to 3.4m USD.
What is Corbus Pharmaceuticals Holdings Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-37%
-37%
The average annual Total Other Income growth rates for Corbus Pharmaceuticals Holdings Inc have been -37% over the past three years .
You don't have any saved screeners yet
